Exhibit 10.39

Execution Copy

THIS AGREEMENT is made on        December 2011 BETWEEN:

1. TEVA PHARMACEUTICALS EUROPE B.V. having its registered office in Mijdrecht,
The Netherlands (the “Company”); and

2. Mr. ROB KOREMANS, residing at (6247 AA) Gronsveld, Rijksweg 45, the
Netherlands (the “Employee”).

THE PARTIES AGREE AS FOLLOWS:

 

1. TERMS AND EMPLOYMENT

 

1.1. The Company shall engage the Employee and the Employee shall serve the
Company in the role of President and CEO of the Company under the terms and
conditions as reflected in the subject Agreement (the “Employment” respectively
the “Agreement”). In this respect the Employee shall be appointed as board
member (“bestuurder”) of the Company. Employee accepts such appointment in
advance.

 

1.2. Employee shall, at the Company’s request, and as part of his obligations
under the Employment, at all times be willing to perform work for its parent
company, its subsidiaries and in general its group companies within the meaning
of article 2:24b Dutch Civil Code (each such parent company, subsidiary and/or
group company to be defined as a “Group Company” and jointly as: the “Group
Companies”) and shall, if so requested, accept appointment as board member under
Dutch law of a Group Company or as officer of such Group Company under the laws
governing that Group Company, without being entitled to any remuneration in
respect of the activities performed for such Group Company in addition to the
remuneration included in this Agreement. The Employee acknowledges that as part
of the Employee’s responsibilities under this Agreement, the Employee will also
function as Vice President of Teva Pharmaceutical Industries Ltd.

 

1.3. This Agreement will enter into effect on 1 March 2012 or any other earlier
or later date as shall be mutually agreed upon in writing by the parties hereto
(the “Effective Date”). The Company shall procure that all necessary steps
(including the preparation and passing of a resolution of the general meeting of
shareholders) shall be taken in order to formalize the appointment of Employee
as “bestuurder”.

 

1.4. This Agreement is for an indefinite period of time. Both the Company and
the Employee are entitled to terminate this Agreement with due of observance of
a notice period of three months for the Employee and six months for the Company.
Last mentioned notices periods do not apply in case of an instant dismissal in
accordance with article 7:677 Dutch Civil Code.

 

1.5.

The Employment will be on a full-time basis. The normal working hours of the
Employee shall be in accordance with all applicable regulations as well as the
Company’s policies. However, the Employee acknowledges that in view of his
senior position, it is expected from the Employee that he shall work irregular
hours, if the situation so requires. The Employee is neither entitled to any
compensation for such irregular hours nor for any hours worked in excess of the
regular hours on a full-time basis.

--------------------------------------------------------------------------------

Execution Copy

 

 

2. DUTIES

 

2.1. During the Employment, the Employee shall devote his time and attention to
the duties assigned to him and shall perform the duties normally associated with
the position of “bestuurder” and specifically with the roles of CEO of the
Company and VP of Teva Pharmaceutical Industries Ltd. During the Employment, the
Employee will, with due observance of clause 10.1 hereof, not be engaged, in any
other work, position, task or activity (for the benefit of) and third party,
which are outside the scope of his Employment, whether or not such work,
position, task or activity is pursued for gain, profit or other pecuniary
advantage, without the prior written consent of the General Meeting of
shareholders of the Company (the “GM”). Such consent shall be considered given
by the GM in respect of the side-activities as listed in Annex 1 to this
Agreement. Notwithstanding the foregoing, the GM shall not withhold its consent
from Employee holding a public or other position, unless the GM believes, in
good faith, that such position may have a detrimental effect on the performance
of Employee’s task and duties under this Agreement, or may cause a conflict of
interest between his position in the Company and the other position.

 

2.2. These duties include, but are not limited to:

  •   the day-to-day management of (the affairs of) the Company;

 

  •   the determination and performance of the policy of the Company;

 

  •   the representation of the Company.

 

2.3. As a board member (bestuurder) of the Company, Employee shall observe all
obligations arising from Dutch law, the articles of association of the Company,
any charter of the board (‘bestuursreglement’) and any and all instructions
and/or resolutions that are or may be adopted by the GM. Employee shall in
addition strictly adhere to and obey all of the written rules, regulations and
policies, in effect within the Company as per the Effective Date or as
subsequently adopted or modified by the Company and provided to Employee, which
govern the operation of the business of the Company and the conduct of employees
of the Company.

 

2.4. To the extent Employee will be appointed as board member (“bestuurder”) or
officer of any Group Company under Dutch law or under the laws governing that
Group Company, Employee shall observe all obligations arising from Dutch law
respectively the laws governing that Group Company, the articles of association
or the equivalent thereof under any law system of such Group Company, any
charter of the board of such Group Company and any and all instructions and/or
resolutions that are or may be adopted by the (general meeting of) shareholders
or, if competent to render such instructions binding Employee in his capacity of
“bestuurder” or officer, by the board or any supervisory board of such Group
Company. Employee shall in addition strictly adhere to and obey all of the
written rules, regulations and policies, in effect within the relevant Group
Company as per the Effective Date or as subsequently adopted or modified by the
Group Company and provided to Employee, which govern the operation of the
business of the Group Company and the conduct of employees of the Group Company.

 

3. VACATION ENTITLEMENT

 

3.1. During the Employment the Employee shall be entitled to 30 vacation days
per calendar year, accruing on a pro rata tempore basis.

--------------------------------------------------------------------------------

Execution Copy

 

 

4. REMUNERATION

 

4.1. For remuneration for his services hereunder, the Employee shall be paid a
fixed gross base salary of EUR 550,000 per annum, which is inclusive of the
statutory Dutch holiday allowance of 8% (the “Salary”). The Salary shall be
payable by bank credit transfer in twelve (12) equal monthly installments in
arrears on or before the last working day of each calendar month.

 

4.2. At the beginning of each calendar year, the GM will set quantitative as
well as qualitative objectives, that should be met by the Employee in the
relevant calendar year and which will be based on the business plans of the
Company (the “Objectives”). In case no Objectives will be set for any calendar
year, the Objectives as set for the preceding calendar year will continue
applying. Depending on the achievement of the Objectives set for any given
calendar year, Employee may be entitled to a gross bonus over that calendar year
(the “Bonus”) as follows. If the Objectives will be met in full (100% of
Objectives met), Employee will be entitled to a Bonus equal to 75% of the Salary
(“On Target Bonus”). If the Objectives will be met for less than 85%, Employee
will not be entitled to any Bonus. If 85% or more (but less than 100%) of the
Objectives will be met, Employee will be entitled to a Bonus to be set by the GM
in its discretion as a percentage of the Salary falling somewhere within the
range from 0% (zero) to 75% of the Salary. In case of over-achievement of the
Objectives (i.e. in case the Objectives will be exceeded), Employee will be
entitled to a Bonus to be set by the GM in its discretion as a percentage of the
Salary falling somewhere within the range from 75% to 83% of the Salary.

 

4.3. The Employee is entitled to a ‘sign-on bonus’ of EUR 400,000 gross (in
words: four hundred thousand Euros) under the condition that Employee will be
employed during at least 30 days following the Effective Date, payable into a
bank account of the Employee to be designated by the Employee within 60 days
from the Effective Date.

 

4.4. Subject tot the approval of the GM, the Employee may participate in the
LTI-plan as included in Annex 1 to this Agreement and as amended from time to
time by the board of Teva Pharmaceutical Industries Ltd. (the “Plan”). The
Employee will receive an initial grant of 500,000 options, in accordance with
the terms and conditions of the Plan.

 

4.5. The Company shall provide the Employee with the right to use a company car
for which the annual all-in operational lease costs for the Company (inclusive
of VAT and all fixed and variable costs, such as full insurance (WA and Casco),
maintenance, repairs and fuel) do not exceed an amount of EUR 24,000 for the
discharge of Employee’s duties under this Agreement and for Employee’s private
use (the “Company Car”). The costs of acquiring and/or leasing the Company Car
together with insurance, running, service, maintenance, repair and fuel costs
will be borne by the Company. The terms and conditions of the Company’s company
car police will additionally apply.

 

4.6. The Employee is entitled to the right of business and private use of a
company-provided cell phone and SIM-card, in accordance with the Company’s
regulations.

 

5. SEVERANCE PAYMENT

If this Agreement will be terminated by the Company other than on the grounds of
an urgent cause as referred to in article 7:677/678 Dutch Civil Code, the
Employee shall be entitled to a gross severance payment of an amount equal to
the sum of the Salary and the most recently applicable On Target Bonus (the
“Pre-fixed Severance”). The Pre-fixed Severance will however be decreased by:

--------------------------------------------------------------------------------

Execution Copy

 

 

  •   any severance awarded to Employee in court rescission proceedings ex
article 7:685 Dutch Civil Code; or

 

  •   any damages awarded to Employee by a court for unfair dismissal
(“kennelijk onredelijke opzegging”) ex article 7:681 Dutch Civil Code.

If the amount of Employee’s entitlements on the basis of any of the above bullet
points exceeds the amount of the Pre-fixed Severance (prior to set-off),
Employee will not be entitled to any Pre-fixed Severance.

 

6. EXPENSES

 

6.1. The Employees shall be entitled to reimbursement of all reasonable
traveling, hotel, dinner, telephone/fax bills, driver service and other
expenses, to the extent such expenses fall within the scope of the Company’s
expense reimbursement policy and will be incurred in the proper performance of
the duties under the Employment. All expenses shall be evidenced in such manner
as the Company may reasonably request.

 

6.2. The Company shall provide the Employee, for a maximum period of three years
calculated as from the Effective Date and subject to continuation of the
Employment during that period, with the right of use of an Company-leased
apartment in (the direct vicinity of) Utrecht for which the annual lease costs
for the Company (inclusive of all variable costs, e.g. utilities, service costs,
parking costs, insurance, taxes and VAT) will not exceed an amount of EUR 4,200
per month.

 

7. D&O INSURANCE

Subject to the acceptance of the Employee by the insurer, he will be included in
the current Directors & Officers (D&O) liability insurance policy concluded by
the Company.

 

8. CONFIDENTIALITY & DATA CARRIERS

 

8.1. The Employee shall, both during the term of this Agreement and after
termination of this Agreement for whatever reason, refrain from using and/or
disclosing in any manner to whomsoever (including to other members of the
Company’s staff, unless such staff members must be informed in connection with
their work for the Company and in such event only upon the express written
authorisation of the GM) any information of a confidential nature concerning
(the business of) the Company, which has become known to Employee as a result of
the employment under this Agreement and which information Employee knew or
should have known to be of a confidential nature, provided however that such
information shall not include any information that is in the public domain or
becomes so available (unless such availability in the public domain is a result
of Employee’s breach of Employee’s obligations pursuant to this Agreement) or
that is lawfully disclosed by Employee to a third party as a consequence of
Employee’s proper performance of Employee’s duties and responsibilities
hereunder (“Confidential Information”).

 

8.2.

Information on or pertinent to, without limitation, the following issues as well
as those issues itself shall be deemed Confidential Information: customers,
customer sales, customer proposals, sale forecasts, methods of operation,
pricing policies, vendors, suppliers (and their terms of business), purchasers,
any proposals relating to the acquisition or disposal of any company owned or
business operated by the Company, any proposals relating to the expansion or
contracting of activities, (business-, research

--------------------------------------------------------------------------------

Execution Copy

 

& development-, construction-, technical-, sales- and production-)plans,
(business-, research & development-, construction-, technical-, sales- and
production-) processes, apparatus, designs, compositions, formula, developments,
research, techniques, improvements, procedures, specifications, ideas, computer
hardware, computer software, methods of accounting, manners of doing business,
the marketing plans, personnel and employment matters (including details of
employees and directors, the level of remuneration and benefits paid to them);

all as acquired, developed, amended, used, generated and/or utilised by or on
behalf of the Company.

 

8.3. The Employee shall not have or keep in the Employee’s private possession in
any manner whatsoever any documents (including notes, records, diaries,
memoranda, worksheets, drawings, minutes of meetings and correspondence as well
as abstracts or summaries thereof), software, computer disks or other data
carriers or media and/or (electronic) copies thereof containing Confidential
Information or otherwise relating to the Company’ business, that have become
available to the Employee as a result of the employment under this Agreement
(“Data Carriers”), except insofar as and for as long as necessary for the proper
performance of the Employee’s duties for the Company.

 

8.4. Upon termination of this Agreement and/or in case of sickness exceeding
three months and/or upon suspension, Employee shall immediately return to the
Company any materials, Data Carriers, keys, Company Car with appurtenances and
any other items belonging to the Company or leased/rented by the Company from
third parties. The Employee shall not withhold any copies of those items.

 

9. INTELLECTUAL PROPERTY RIGHTS

 

9.1. Insofar as the rights specified hereinafter are not vested in the Company
by operation of law on the grounds of the employment relation between the
parties, the Employee hereby explicitly states that the Employee shall transfer
and, insofar as possible, hereby transfers to the Company in advance any
intellectual and/or industrial property rights of whatever nature in or arising
from ideas, concepts, discoveries, inventions, improvements and/or developments
made or acquired by the Employee in the discharge of the Employee’s duties for
the Company.

 

9.2. The Employee shall promptly disclose to the Company fully and completely
any and all of the ideas, concepts, discoveries, inventions, improvements and
developments, made or acquired by the Employee in the discharge of the
Employee’s duties for the Company.

 

9.3. The Employee hereby irrevocably relinquishes/waives for the benefit of the
Company any moral/personal rights as referred to in article 25 sub a, b and c of
the Copyright Act and article 5 of the “Naburige Rechten” Act, that may vest in
the Employee in respect of the work products referred to in the previous
paragraphs of this clause.

 

9.4. The Employee acknowledges that the Salary includes reasonable and
sufficient compensation for the fact that the intellectual and industrial
property rights, referred to above, will vest in the Company by operation of law
or through the transfer to the Company of such rights pursuant to paragraph 1 of
this clause.

 

10. NON-COMPETITION AND NON-SOLICITATION

 

10.1.

During the term of this Agreement, and during a period of twelve (12) months
after the termination of this Agreement, for whatever reason, the Employee shall
not, directly or indirectly, either as an employee, employer, consultant, agent,
principal, partner,

--------------------------------------------------------------------------------

Execution Copy

 

  corporate officer, director, shareholder, member, investor or in any other
individual or representative capacity, engage or participate in or work for any
business that is in competition in any manner whatsoever with the business of
the Company worldwide, including for the avoidance of doubt the business of any
Group Company including without limitation Teva Pharmaceutical Industries Ltd.
The parties agree that the Company has a legitimate interest in protecting the
business and goodwill of the Company that it has developed and that its
affiliates have developed. The parties further agree that the limitations as to
time, geographical area, and scope of activity to be restrained do not impose a
greater restraint upon Employee than is necessary to protect the goodwill or
other business interests of the Company and its affiliates. The Employee agrees
that if a court of competent jurisdiction determines that the length of time or
any other restriction, or portion thereof, set forth in this subject clause is
overly restrictive and unenforceable, the court may reduce or modify such
restrictions to those which it deems reasonable and enforceable under the
circumstances, and as so reduced or modified the parties hereto agree that the
restrictions of this subject clause shall remain in full force and effect. The
Employee further agrees that if a court of competent jurisdiction determines
that any provision of the subject clause is invalid, the remaining provisions of
the subject clause and the remainder of this Agreement shall not be affected
thereby, and shall remain in full force and effect. In case the Employment is
terminated by notice, the term of the subject restrictions shall be reduced as
follows. If the Employee terminates the Employment with observance of the notice
period as set out in clause 1.5, the term of the subject restriction is nine
(9) months. If the Company terminates the Employment with observance of the
notice period as set out in clause 1.5, the term of the subject restriction is
six (6) months.

 

10.2. For the avoidance of doubt, parties agree that the above restrictions will
not apply if the Employee will enter the employment of any affiliate company of
the Company in parallel to the subject Employment or immediately following the
termination of the subject Employment.

 

10.3. The Employee agrees that, during the term of this Agreement and for a
period of twelve (12) months thereafter, he shall not, directly or indirectly,
induce or solicit (or authorize or assist in the taking of any such actions by
any third party) any employee or consultant of the Company or any of its
affiliates to leave his or her business association with such entity.

 

11. PENALTIES

 

11.1. If the Employee breaches any of the obligations stated in the clause 10 of
this Agreement, the Employee shall immediately, without any notice of default
being required, forfeit to the Company a penalty/liquidated damages for each
breach thereof, amounting to EUR 100,000 (one hundred thousand Euros) and a
penalty/liquidated damages amounting to EUR 5,000 (five thousand Euros) for each
day that such breach continues, without prejudice to the Company’s rights to
claim (a) full compliance with the relevant contractual obligations and/or
(b) actual damages instead of the penalty/liquidated damages.

 

11.2. Payment of the penalties referred to in the previous paragraph shall not
release the Employee from the Employee’s obligations as specified in this
Agreement. With respect to the penalties provided for in the previous paragraph
of this clause, the parties to this Agreement intend to derogate from the
provisions of article 7:650 paragraphs 3 and 5 of the Dutch Civil Code both in
respect of the amounts of the penalties and to the extent that these penalties
can be used by the Company for its own benefit.

--------------------------------------------------------------------------------

Execution Copy

 

 

12. DEFINITION OF THE COMPANY

 

12.1. In the clauses 8 up to and including 10 of this Agreement, the Company
shall be deemed to include any and all of its Group Companies.

 

13. INCAPACITY

 

13.1. In case of Employee being incapacitated to perform Employee’s duties under
this Agreement due to sickness or accident and only if and to the extent
wherein, pursuant to article 7:629 Dutch Civil Code, the Company is obliged to
pay salary, the Company will pay to Employee, as from the first day of sickness,
during a maximum period of 104 weeks calculated as from the first day of
sickness: 100% of the Salary, excluding any variable pay.

 

13.2. The continued salary payments as referred to in the previous clause will
be decreased with any amount, to which the Employee is entitled under any
applicable social security or under insurance scheme in the premiums whereof the
Company contributed.

 

13.3. In case the Employee has in connection with his incapacity any claim
against a third party, the Employee shall assign its rights in this respect to
the Company upon the request of the latter. However, only to the extent of the
damages incurred by the Company as a result of the incapacity of the Employee.

 

14. INSURANCE

 

14.1. Subject to the Employee being accepted as an insured party on normal
premium conditions by an insurer designated by the Company, the Company shall
take out an additional disability insurance
(“Arbeidsongeschiktheidsverzekering”) providing benefits of maximally EUR 545
gross per day in case of the Employee being eligible for state disability
benefits (WIA). The premium of this insurance shall be borne by the Company.

 

14.2. Subject to the Employee being accepted as an insured party on normal
premium conditions by an insurer designated by the Company, the Company shall
take out a WAO-gap insurance (“WAO-hiaatverzekering”). The premium of this
insurance shall be borne by the Company.

 

14.3. The Company shall provide for insurance covering for accidents at work and
during business travelling.

 

14.4. The Employee shall provide for insurance cover for his health as well as
his family in line with his existing health care cover. The premium with regard
thereto shall be refunded by the Company. The Employee shall provide the Company
with all relevant documentation with regard to the health insurance at its first
request.

 

15. PENSION

 

15.1. Employee shall participate in the Company’s pension scheme, under the
terms and conditions thereof.

 

15.2. Parties acknowledge that, as a new employer, the Company shall not have
any further obligations towards the Employee with respect to his pension,
including with respect to differences in salary during his past employment.

--------------------------------------------------------------------------------

Execution Copy

 

 

16. GOVERNING LAW/JURISDICTION

This Agreement shall be governed by and construed in accordance with the laws of
the Netherlands. Any conflict under this Agreement, which cannot be settled
amicably, shall be submitted to the jurisdiction of a competent court of law in
the Netherlands.

IN WITNESS whereof the parties hereto have executed this Agreement in two
original copies on the day and year first written above.

 

At                                                  At
                                         Teva Pharmaceuticals Europe B.V.   

 

                                                
/s/ Rob Koremans                   
in this matter represented by its sole shareholder    Mr. Rob Koremans    Teva
Pharmaceutical Industries Ltd       By:
                                                    Title: